Aspen posts lower half-year profit

Aspen has reported a 15% drop in interim headline earnings per share dropping. The drugmaker says the decline was mainly due to inflationary pressures, supply chain issues as well as the loss of COVID vaccine sales. Business Day TV caught up with the CEO, Stephen Saad for more detail on the performance.